Barsouk A, Peele K A, Kiljanski J, Stolarski C, Nebes V, Kennerdell J S, Volpe R, Wall J R
Thyroid Eye Disease Research Laboratory, Allegheny-Singer Research Institute, Pittsburgh, Pennsylvania 15212, USA.
J Endocrinol Invest. 1996 Jun;19(6):334-41. doi: 10.1007/BF03344966.
We have carried out tests for antibody-dependent cell-mediated cytotoxicity (ADCC) against extra ocular muscle (EOM), Müller's muscle, orbital fibroblasts and skeletal muscle in patients with thyroid-associated ophthalmopathy (TAO) and related eye disorders. Cytotoxicity was measured as lactate dehydrogenase (LDH) release and results expressed as % cytotoxicity. Tests were positive, with EOM cells, in 65% of patients with TAO, 75% with ocular myopathy, a variant of TAO in which periorbital inflammation is minimal, 50% with euthyroid Graves' disease defined as ophthalmopathy associated with subclinical thyroiditis and in 50% of patients with stable lid lag and retraction but no other signs of progressive ophthalmopathy, but in only 13% of patients with Graves' hyperthyroidism without ophthalmopathy, 10% with Hashimoto's thyroiditis and 14% of patients with other thyroid disorders. Tests were positive, with Müller's muscle cells, in 40% of patients with TAO, 25% with ocular myopathy, 40% with euthyroid Graves' disease, 44% with lid lag, 19% with Graves'hyperthyroidism, 50% with Hashimoto's thyroiditis and in 37.5% of patients with other thyroid disorders. When skeletal muscle cells were used as target, tests were positive in 13% of patients with TAO, 31% with lid lag, 25% with Graves' hyperthyroidism and in 29% of patients with Hashimoto's thyroiditis, but in no patient with euthyroid Graves' disease or other thyroid disorders. Tests were negative in all patients and normals tested when EOM-derived fibroblasts were used as targets in ADCC. A significant positive correlation between % cytotoxicity against EOM cells and the severity of the eye muscle dysfunction expressed as an eye muscle index, was observed in patients with TAO. There was a significant negative correlation between the duration of eye disease and % cytotoxicity against EOM cells, suggesting higher titers of cytotoxic antibodies in the early stages of TAO. There was no correlation between % cytotoxicity and serum level of anti-TSH receptor antibodies, measured in a radioreceptor assay. These findings suggest that autoimmunity against Müller's muscle may play a role in the pathogenesis of persistent lid lag and retraction. The nature of the EOM and Müller's muscle autoantigens recognized by cytotoxic antibodies in the serum of patients with TAO and related eye disorders is unknown.
我们对甲状腺相关性眼病(TAO)及相关眼部疾病患者的眼外肌(EOM)、米勒肌、眼眶成纤维细胞和骨骼肌进行了抗体依赖性细胞介导的细胞毒性(ADCC)检测。细胞毒性通过乳酸脱氢酶(LDH)释放来测定,结果以细胞毒性百分比表示。以EOM细胞为靶细胞时,检测结果呈阳性的患者比例如下:TAO患者为65%,眼肌病(TAO的一种变体,眶周炎症轻微)患者为75%,甲状腺功能正常的格雷夫斯病(定义为与亚临床甲状腺炎相关的眼病)患者为50%,有稳定的眼睑滞后和退缩但无其他进行性眼病体征的患者为50%,而无眼病的格雷夫斯甲亢患者仅为13%,桥本甲状腺炎患者为10%,其他甲状腺疾病患者为14%。以米勒肌细胞为靶细胞时,检测结果呈阳性的患者比例如下:TAO患者为40%,眼肌病患者为25%,甲状腺功能正常的格雷夫斯病患者为40%,有眼睑滞后的患者为44%,格雷夫斯甲亢患者为19%,桥本甲状腺炎患者为50%,其他甲状腺疾病患者为37.5%。以骨骼肌细胞为靶细胞时,检测结果呈阳性的患者比例如下:TAO患者为13%,有眼睑滞后的患者为31%,格雷夫斯甲亢患者为25%,桥本甲状腺炎患者为29%,而甲状腺功能正常的格雷夫斯病患者或其他甲状腺疾病患者均为阴性。当以EOM来源的成纤维细胞为ADCC靶细胞时,所有检测患者及正常人均为阴性。在TAO患者中,观察到针对EOM细胞的细胞毒性百分比与以眼肌指数表示的眼肌功能障碍严重程度之间存在显著正相关。眼病病程与针对EOM细胞的细胞毒性百分比之间存在显著负相关,提示TAO早期细胞毒性抗体滴度较高。细胞毒性百分比与放射受体分析中测得的抗促甲状腺激素受体抗体血清水平之间无相关性。这些发现表明,针对米勒肌的自身免疫可能在持续性眼睑滞后和退缩的发病机制中起作用。TAO及相关眼部疾病患者血清中细胞毒性抗体识别的EOM和米勒肌自身抗原的性质尚不清楚。